Cliical Trials: Risk Assessment Categorization Tool (RACT)

Regulatory Expectations for RACT Documentation in RBM Submissions Regulatory Expectations for RACT Documentation in RBM Submissions In the rapidly evolving landscape of clinical trials, effective monitoring strategies are pivotal for ensuring data integrity and patient safety. The Risk-Based Monitoring (RBM) approach, particularly in conjunction with the Risk Assessment Categorization Tool (RACT), has emerged as a…

Read More “Regulatory Expectations for RACT Documentation in RBM Submissions” »

Refreshing RACT Throughout the Study Lifecycle: When and How The Risk Assessment Categorization Tool (RACT) plays a crucial role in enhancing clinical trial oversight through effective risk-based monitoring (RBM). Addressing the need for a structured approach to risk assessments, RACT is an essential tool for clinical operations, regulatory affairs, and medical affairs professionals engaged in…

Read More “Refreshing RACT Throughout the Study Lifecycle: When and How” »

Linking RACT to CtQ Factors, QTLs and Vendor Oversight In the evolving landscape of clinical trials, optimizing oversight mechanisms is imperative for ensuring compliance and data integrity. This step-by-step guide focuses on the Risk Assessment Categorization Tool (RACT), its correlation with Critical to Quality (CtQ) factors, Quality Tolerance Limits (QTLs), and the significance of vendor…

Read More “Linking RACT to CtQ Factors, QTLs and Vendor Oversight” »

Inspection Case Studies: When Weak RACT Drove Serious Quality Issues Inspection Case Studies: When Weak RACT Drove Serious Quality Issues In the rapidly evolving landscape of clinical trials, adhering to regulatory requirements and standards of quality becomes paramount. The advent of risk-based monitoring (RBM) and remote oversight has introduced new methodologies and tools, such as…

Read More “Inspection Case Studies: When Weak RACT Drove Serious Quality Issues” »

RACT for Decentralized and Hybrid Trial Designs RACT for Decentralized and Hybrid Trial Designs The clinical research landscape is evolving, especially with the rapid adoption of decentralized and hybrid trial designs. The introduction of the Risk Assessment Categorization Tool (RACT) provides a structured method for evaluating risks associated with clinical trials. In this comprehensive guide,…

Read More “RACT for Decentralized and Hybrid Trial Designs” »

RACT Best Practices for Sponsors, CROs and Site Networks RACT Best Practices for Sponsors, CROs and Site Networks In the landscape of clinical trials, the Risk Assessment Categorization Tool (RACT) serves as a pivotal component for ensuring compliance and enhancing patient safety. As the industry shifts toward Risk-Based Monitoring (RBM) and remote oversight, it becomes…

Read More “RACT Best Practices for Sponsors, CROs and Site Networks” »